A fatty acid-rich fraction of an endolichenic fungus Phoma sp. suppresses immune checkpoint markers via AhR/ARNT and ESR1-Reference-Cited by-同舟云学术

A fatty acid-rich fraction of an endolichenic fungus Phoma sp. suppresses immune checkpoint markers via AhR/ARNT and ESR1

Published:2023-09 Issue:9 Volume:9 Page:e19185
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Varlı Mücahit^ORCID,Ngo Men Thi,Kim Seong-Min,Taş İsa^ORCID,Zhou Rui,Gamage Chathurika D.B.,Pulat Sultan^ORCID,Park So-Yeon,Sesal Nüzhet Cenk,Hur Jae-Seoun^ORCID,Kang Kyo Bin^ORCID,Kim Hangun^ORCID

Funder

Türkiye Bilimsel ve Teknolojik Araştırma Kurumu

Ministry of Science, ICT and Future Planning

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference63 articles.

1. S.S. Ramalingam, T.K. Owonikoko, F.R. Khuri, Lung Cancer: New Biological Insights and Recent Therapeutic Advances, CA: A Cancer Journal for Clinicians, 61: 91-112. https://doi.org/10.3322/caac.20102.

2. Inflammatory and tumorigenic effects of environmental pollutants found in particulate matter on lung epithelial cells;Taş;Toxicol. Vitro,2019

3. A. Hu, J. Liu, Y. Wang, M. Zhang, Y. Guo, Y. Qin, T. Liu, Y. Men, Q. Chen, T. Liu, Discovery of rafoxanide as a novel agent for the treatment of non-small cell lung cancer, Sci. Rep.. 13 (123AD) 693. https://doi.org/10.1038/s41598-023-27403-y.

4. Comparative efficacy and safety of PD-1/PD-L1 Inhibitors versus platinum-based chemotherapy for the first-line treatment of advanced non-small cell lung cancer: a meta analysis of randomized controlled trials;Li;Pharmacol. Res.,2020

5. Non-small cell lung cancer: current treatment and future advances;Zappa;Transl. Lung Cancer Res.,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endolichenic Fungi: A Promising Medicinal Microbial Resource to Discover Bioactive Natural Molecules—An Update;Journal of Fungi;2024-01-25